Patents by Inventor Michel Leon Thominet

Michel Leon Thominet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating a mammal afflicted with hypotension with dialkylaminoalkyl ethers of 2-alkoxy-3,5-dihalobenzene and salts thereof
    Patent number: 3995038
    Abstract: Hypotension in mammals is effective relieved by the administration of dialkylaminoalkyl ethers of 2-alkoxy-3,5-dihalobenzenes. The compounds are relatively non-toxic in dosages required to alleviate such conditions.
    Type: Grant
    Filed: April 26, 1976
    Date of Patent: November 30, 1976
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventor: Michel Leon Thominet
  • Methods of treating a mammal afflicted with excessive histamine with dialkylaminoalkyl ethers of 2-alkoxy-3,5-dihalobenzene and salts thereof
    Patent number: 3995036
    Abstract: Excessive histamine in mammals is effectively relieved by the administration of dialkylaminoalkyl ethers of 2-alkoxy-3,5-dihalobenzenes. The compounds are relatively non-toxic in dosages required to alleviate such condition.
    Type: Grant
    Filed: April 26, 1976
    Date of Patent: November 30, 1976
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventor: Michel Leon Thominet
  • Methods of treating a mammal afflicted with pain with dialkylaminoalkyl ethers of 2-alkoxy-3,5-dihalobenzene and salts thereof
    Patent number: 3995037
    Abstract: Pain in mammals is effectively relieved by the administration of dialkylaminoalkyl ethers of 2-alkoxy-3,5-dihalobenzenes. The compounds are relatively non-toxic in dosages required to alleviate such condition.
    Type: Grant
    Filed: April 26, 1976
    Date of Patent: November 30, 1976
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventor: Michel Leon Thominet
  • Methods of treating a mammal afflicted with convulsions, with dialkylaminoalkyl ethers of 2-alkoxy-3,5-dihalobenzene and salts thereof
    Patent number: 3978218
    Abstract: Convulsions, pain, excessive histamine or hypotension in mammals are effectively relieved by the administration of dialkylaminoalkyl ethers of 2-alkoxy-3,5-dihalobenzenes. The compounds are relatively non-toxic in dosages required to alleviate such conditions.
    Type: Grant
    Filed: May 13, 1975
    Date of Patent: August 31, 1976
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventor: Michel Leon Thominet
  • Methods of protection against emesis in mammals by administration of a 3-alkoxy-thianaphthene-2-carboxamide
    Patent number: 3976780
    Abstract: Emesis in mammals is prevented by administration of 3-alkoxy-thianaphthene-2-carboxamides in a daily dosage ranging from 50 to 500 .mu.g/kg as determined by a physician or veterinarian. When administered to dogs in a daily dosage of 250 .mu.g/kg, 100% protection is obtained against vomiting normally induced by subcutaneous administration of apomorphine.
    Type: Grant
    Filed: January 6, 1975
    Date of Patent: August 24, 1976
    Assignee: Societe d'Etudes Scientifiques et Industrielles l'Ile-de-France
    Inventor: Michel Leon Thominet
  • Methods of protection against emesis in mammals by administration of a heterocyclic benzamide
    Patent number: 3959477
    Abstract: The heterocyclic benzamides of this invention are particularly effective for the treatment of emesis in mammals. For example, when they are administered to dogs in relatively small dosage, they afford 100% protection against vomiting. They are also non-toxic in dosages for effecting complete control of vomiting.
    Type: Grant
    Filed: March 24, 1975
    Date of Patent: May 25, 1976
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventor: Michel Leon Thominet
  • 3-Alkoxy-thianapthene-2-carboxamides
    Patent number: 3954748
    Abstract: The 3-alkoxy-thianaphthene-2-carboxamides of this invention are effective for the treatment of mammals afflicted with emesis. When administered to dogs in dosages of 250 .mu.g/kg, compounds of this invention give 100% protection against vomiting normally induced by subcutaneous administration of apomorphine. The compounds of this invention also favorably modify behavior disturbances in mammals.
    Type: Grant
    Filed: June 26, 1974
    Date of Patent: May 4, 1976
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventor: Michel Leon Thominet